Sesen Bio Inc (SESN)

[pijoe]

I haven't seen the endpoint parameters of this trial(Vicinium phase 3). Is there a response percentage to proceed with approval?? Do they need to continue the 40 percent plus response rate? I would assume minimal side effects and anything over 8-10 percent would lead to approval. Just started investing a little bit in this stock so still sitting through the info and fundamentals.. looks promising as does the potential on Proxinium even though it's still early to make a good judgement on it.